Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
14 January 2022Website:
http://cardiodiagnosticsinc.comNext earnings report:
30 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:35:15 GMTDividend
Analysts recommendations
Institutional Ownership
CDIO Latest News
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will sponsor a booth and showcase its groundbreaking cardiovascular solutions at the 2024 Onsite Employee Health Clinics Forum.
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced the successful completion of its System and Organization Controls (SOC) 2 Type I audit.
Cardio Diagnostics Holdings shares added more than 75% on Monday after positive results from a trial of the company's coronary heart disease (CHD) test PrecisionCHD were published in the Journal of the American Heart Association. The company noted that PrecisionCHD is a non-invasive and more accessible alternative to current CHD diagnosis tools being in the form of a blood test that uses AI and personalized genetic and epigenetic information to sensitively detect the presence of CHD.
Shares of cardiovascular medicine specialist Cardio Diagnostics (NASDAQ: CDIO ) are skyrocketing on Tuesday following the announcement of a key deal. Specifically, Vizient has awarded Cardio Diagnostics an “Innovation Technology” contract for its artificial intelligence (AI) driven molecular heart disease tests.
What type of business is Cardio Diagnostics Holdings?
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
What sector is Cardio Diagnostics Holdings in?
Cardio Diagnostics Holdings is in the Healthcare sector
What industry is Cardio Diagnostics Holdings in?
Cardio Diagnostics Holdings is in the Biotechnology industry
What country is Cardio Diagnostics Holdings from?
Cardio Diagnostics Holdings is headquartered in United States
When did Cardio Diagnostics Holdings go public?
Cardio Diagnostics Holdings initial public offering (IPO) was on 14 January 2022
What is Cardio Diagnostics Holdings website?
https://cardiodiagnosticsinc.com
Is Cardio Diagnostics Holdings in the S&P 500?
No, Cardio Diagnostics Holdings is not included in the S&P 500 index
Is Cardio Diagnostics Holdings in the NASDAQ 100?
No, Cardio Diagnostics Holdings is not included in the NASDAQ 100 index
Is Cardio Diagnostics Holdings in the Dow Jones?
No, Cardio Diagnostics Holdings is not included in the Dow Jones index
When does Cardio Diagnostics Holdings report earnings?
The next expected earnings date for Cardio Diagnostics Holdings is 30 August 2024